EYE 4.76% 20.0¢ nova eye medical limited

Ann: Ellex Company Update, page-6

  1. 4,695 Posts.
    lightbulb Created with Sketch. 72
    Bell Potter initiated cover yesterday. Here's a wee snip

    "Investment View – Initiate with a Buy, PT $1.92 We initiate coverage on ELX with a Buy and PT of $1.92. The PT is generated using a blend of three valuation methodologies: DCF, EV/EBITDA and EV/Sales. ELX has aggressive growth potential and we forecast strong double digit growth in revenue and earnings over the next 5 years. We also believe ELX is undervalued when compared to the high growth small cap medtech companies in the US trading at an average 6.8x 2018 EV/sales vs. ELX trading at 1.5x. In our view, iTrack business alone can support our PT for ELX given the US$500m-US$700m recent acquisitions in the MIGS space. "

    losses expected in their forward calc's for both this year and next year, so need to see through that I guess.
 
watchlist Created with Sketch. Add EYE (ASX) to my watchlist
(20min delay)
Last
20.0¢
Change
-0.010(4.76%)
Mkt cap ! $45.81M
Open High Low Value Volume
20.5¢ 20.5¢ 19.0¢ $139.6K 703.9K

Buyers (Bids)

No. Vol. Price($)
5 100510 19.0¢
 

Sellers (Offers)

Price($) Vol. No.
20.0¢ 94295 2
View Market Depth
Last trade - 16.10pm 04/09/2024 (20 minute delay) ?
EYE (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.